Retention and Urine Submissions
Of 5760 scheduled samples, 3917 samples (68.0%) were submitted. When collapsed across incentive conditions, there were no significant differences between participants receiving placebo vs those receiving bupropion SR in the percentage of urine samples submitted (2059 of 2880 samples [71.5%] vs 1854 of 2880 samples [64.4%]; 